Psychotropic medication tied to fracture risk

Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Takeaway

  • A large population cohort shows an increased risk for fracture in patients taking selective serotonin reuptake inhibitors (SSRIs), antipsychotics, and benzodiazepines.

Why this matters

  • The study suggests that psychotropic medication use is a risk factor for fractures.

Study design

  • The researchers analyzed data from 68,730 individuals (62,275 women; age, 40 y and older) who underwent a baseline bone mineral density assessment between January 1, 1996 and March 28, 2013. Fracture risk was assessed on March 28, 2013.
  • Funding: None disclosed.

Key results

  • 18.9% of participants had mental disorders, and 17.4% used psychotropic medications.
  • Risk for nontraumatic major osteoporotic fractures was heightened in those taking SSRIs (adjusted HR [aHR], 1.47), antipsychotics (aHR, 1.48), and benzodiazepines (aHR, 1.16).
  • Hip fracture risks was also heightened in SSRI use (aHR, 1.51), antipsychotics (aHR, 2.18), and benzodiazepines (aHR, 1.23).

Limitations

  • The study cannot prove causation.
  • The study applies best to older people who are considered at risk for osteoporosis.